bf/NASDAQ:ACAD_icon.jpeg

COM:ACADIA

Acadia Pharmaceuticals

  • Stock

Last Close

16.18

22/11 21:00

Market Cap

2.72B

Beta: -

Volume Today

1.40M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
1.15M
-
120K
89.52%
61K
49.17%
17.33M
28,311.48%
124.90M
620.68%
223.81M
79.19%
339.08M
51.50%
441.75M
30.28%
484.14M
9.60%
517.24M
6.83%
726.44M
40.45%
cost of revenue
4.41M
-
13.06M
196.41%
18.33M
40.35%
19.60M
6.92%
20.55M
4.86%
19.14M
6.86%
10.17M
46.89%
45.73M
349.84%
gross profit
1.15M
-
120K
89.52%
61K
49.17%
12.93M
21,088.52%
111.84M
765.31%
205.48M
83.72%
319.48M
55.48%
421.20M
31.84%
465.00M
10.40%
507.07M
9.05%
680.71M
34.24%
selling and marketing expenses
general and administrative expenses
12.72M
-
32.75M
157.45%
90.80M
177.28%
186.46M
105.34%
255.06M
36.79%
265.76M
4.19%
325.64M
22.53%
388.66M
19.35%
396.03M
1.90%
selling general and administrative expenses
12.72M
-
32.75M
157.45%
90.80M
177.28%
186.46M
105.34%
255.06M
36.79%
265.76M
4.19%
325.64M
22.53%
388.66M
19.35%
396.03M
1.90%
369.09M
6.80%
402.47M
9.04%
research and development expenses
26.72M
-
60.60M
126.79%
73.87M
21.89%
99.28M
34.41%
149.19M
50.26%
187.16M
25.45%
240.38M
28.44%
319.13M
32.76%
239.41M
24.98%
361.57M
51.02%
351.62M
2.75%
other expenses
2.50M
-
1.33M
46.76%
3.98M
199.25%
-1.84M
146.20%
997K
154.18%
-997K
200%
2.33M
333.60%
3.54M
52.08%
5.11M
44.24%
cost and expenses
39.44M
-
93.35M
136.68%
164.67M
76.40%
290.15M
76.20%
417.31M
43.83%
471.25M
12.93%
585.62M
24.27%
728.34M
24.37%
654.58M
10.13%
740.83M
13.18%
799.82M
7.96%
operating expenses
39.44M
-
93.35M
136.68%
164.67M
76.40%
285.74M
73.52%
404.25M
41.48%
452.92M
12.04%
566.02M
24.97%
707.79M
25.05%
635.44M
10.22%
730.66M
14.99%
754.09M
3.21%
interest expense
6.61M
-
ebitda
-38.22M
-
-93.23M
143.94%
-164.61M
76.57%
-272.81M
65.73%
-292.41M
7.18%
-247.44M
15.38%
-246.54M
0.36%
-286.59M
16.24%
-170.44M
40.53%
-223.60M
31.19%
-67.83M
69.67%
operating income
-38.30M
-
-93.23M
143.44%
-164.61M
76.57%
-272.81M
65.73%
-292.41M
7.18%
-247.44M
15.38%
-246.54M
0.36%
-286.59M
16.24%
-170.44M
40.53%
-223.60M
31.19%
-73.38M
67.18%
depreciation and amortization
79K
-
206K
160.76%
647K
214.08%
1.83M
182.53%
2.71M
48.41%
3.00M
10.76%
2.77M
7.95%
2.93M
6.00%
3.34M
14.05%
2.03M
39.41%
5.55M
174.04%
total other income expenses net
349K
-
755K
116.33%
499K
33.91%
2.76M
453.71%
4.13M
49.33%
-1.84M
144.60%
12.16M
760.98%
5.61M
53.85%
2.92M
47.98%
10.15M
247.67%
22.34M
120.08%
income before tax
-37.95M
-
-92.47M
143.69%
-164.11M
77.47%
-270.05M
64.55%
-288.28M
6.75%
-243.94M
15.38%
-234.38M
3.92%
-280.97M
19.88%
-167.52M
40.38%
-213.44M
27.41%
-51.04M
76.09%
income tax expense
-206K
-
330K
260.19%
1.34M
306.36%
1.12M
16.55%
1.26M
12.24%
876K
30.25%
611K
30.25%
351K
42.55%
2.53M
621.08%
10.25M
304.98%
net income
-37.95M
-
-92.47M
143.69%
-164.44M
77.82%
-271.39M
65.04%
-289.40M
6.64%
-245.19M
15.28%
-235.26M
4.05%
-281.58M
19.69%
-167.87M
40.38%
-215.97M
28.66%
-61.29M
71.62%
weighted average shs out
85.72M
-
97.25M
13.46%
100.63M
3.48%
115.86M
15.13%
122.60M
5.82%
126.58M
3.25%
147.20M
16.29%
157.33M
6.88%
160.49M
2.01%
161.68M
0.74%
163.82M
1.32%
weighted average shs out dil
85.72M
-
97.25M
13.46%
100.63M
3.48%
115.86M
15.13%
122.60M
5.82%
126.58M
3.25%
147.20M
16.29%
157.33M
6.88%
160.49M
2.01%
161.68M
0.74%
163.82M
1.32%
eps
-0.44
-
-0.95
115.91%
-1.63
71.58%
-2.34
43.56%
-2.36
0.85%
-1.94
17.80%
-1.60
17.53%
-1.79
11.87%
-1.05
41.34%
-1.34
27.62%
-0.37
72.39%
epsdiluted
-0.44
-
-0.95
115.91%
-1.63
71.58%
-2.34
43.56%
-2.36
0.85%
-1.94
17.80%
-1.60
17.53%
-1.79
11.87%
-1.05
41.34%
-1.34
27.62%
-0.37
72.39%

All numbers in (except ratios and percentages)